Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT) (COVIDPROIMPACT)

Impact of the COVID-19 Pandemic on the Quality of Psychological Life of Healthcare Professionals

The COVID-19 pandemic is profoundly changing the way people live and work. After the health impact, it is the mental and psychological impact that reaches varying degrees in the entire world population. The previous Asian epidemics have had a lasting impact on the health professionals concerned.

In France, no study has yet assessed the psychological impact of this health crisis on the level of health professionals. Investigators propose to study prospectively the evolution of the state of stress and anxiety of all the professionals practicing within the gynecology-obstetrics departments of 18 French hospitals.

Investigators also hypothesize that the mental repercussions in terms of stress and anxiety within the same service could be different depending on the professional status and the place of exercise (the French regions being impacted in different ways).

In addition to the epidemiological interest, the results of this study may help us to target regions and professionals who will need psychological support during and after this serious health crisis.

Study Overview

• Status: Completed
• Conditions: Stress, Psychological; Covid 19
• Intervention / Treatment: Other: Questionnaires on psychological quality of life

• Study Type: Observational
• Enrollment (Actual): 1565

Contacts and Locations

Study Locations

• France
  • Angers, France
    • Gynécologie-Obstétrique CHU de Angers
  • Bordeaux, France
    • Gynécologie-Obstétrique Hôpital Pellegrin
  • Brest, France
    • Gynécologie-Obstétrique CHRU de Brest
  • Bron, France, 69677
    • Gynaecology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon
  • Clamart, France
    • Gynécologie-Obstétrique Hôpital Antoine Béclère (APHP)
  • La Tronche, France
    • Gynécologie-Obstétrique CHU Grenoble-Alpes, Hôpital Couple Enfant
  • Le Kremlin-Bicêtre, France
    • Gynécologie-Obstétrique Hôpital BICETRE (APHP)
  • Lille, France
    • Gynécologie-Obstétrique Hôpital Jeanne de Flandre - CHRU Lille
  • Limoges, France
    • Gynécologie-Obstétrique Hôpital de la Mère et de l'Enfant
  • Lyon, France, 69317
    • Gynécologie-Obstétrique Hôpital de la Croix Rousse
  • Marseille, France
    • Gynécologie-Obstétrique Hôpital La Conception
  • Paris, France
    • Gynécologie-Obstétrique Hôpital de la Pitié Salpêtrière (APHP)
  • Paris, France
    • Gynécologie-Obstétrique Maternité Port-Royal, Groupe Hospitalier Cochin-Broca- Hotel Dieu (APHP)
  • Poitiers, France
    • Gynécologie-Obstétrique CHU de Poitiers
  • Reims, France
    • Gynécologie-Obstétrique CHU Reims - Institut Mère Enfant Alix de Champagne
  • Rennes, France
    • Gynécologie-Obstétrique CHU de Rennes
  • Saint-Étienne, France
    • Gynécologie-Obstétrique CHU de Saint Etienne
  • Strasbourg, France
    • Gynécologie-Obstétrique Hôpital de Hautepierre

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Person over 18 years of age practicing a health profession in the participating gynecology and obstetrics departments

Description

Inclusion Criteria:

• person over 18
• person exercising a profession in the health field
• person having expressed his non-opposition

Exclusion Criteria:

• inability to understand the information given and the questionnaire
• person deprived of liberty, person under guardianship.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Stress state score, during the confinement period	Stress state score, during the confinement period, established by a comparison VAS (visual analogue scale) compared to a period outside COVID-19 (from -5: considerable degradation to +5: considerable improvement, with 0: no change)	About 10 minutes ( Questionnaire filling time)

Collaborators and Investigators

• Sponsor: Hospices Civils de Lyon

Study record dates

Study Major Dates

• Study Start (Actual): May 7, 2020
• Primary Completion (Actual): July 15, 2020
• Study Completion (Actual): July 15, 2020

Study Registration Dates

• First Submitted: May 4, 2020
• First Submitted That Met QC Criteria: May 4, 2020
• First Posted (Actual): May 5, 2020

Study Record Updates

• Last Update Posted (Actual): December 21, 2020
• Last Update Submitted That Met QC Criteria: December 17, 2020
• Last Verified: December 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Behavioral Symptoms; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19; Stress, Psychological
• Other Study ID Numbers: 69HCL20_0413

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No